Ä¿³ØÆ¼µå ¾à¹°Àü´Þ ±â±â ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, Åõ¿© °æ·Îº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Connected Drug Delivery Devices Market, By Product Type, By Application, Route of Administration, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1605699
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 388 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,702,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,728,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 8,174,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

Ä¿³ØÆ¼µå ¾à¹°Àü´Þ ±â±â ½ÃÀå ±Ô¸ð´Â 2023³â 5Á¶ 1,234¾ï 5,000¸¸ ´Þ·¯·Î 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 23.5%ÀÇ ¼ºÀå·üÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Ä¿³ØÆ¼µå ¾à¹°Àü´Þ ±â±â ½ÃÀå : ½ÃÀå ¿ªÇÐ

½º¸¶Æ®Çϰí È¿À²ÀûÀÎ ¾à¹°Àü´Þ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

´ç´¢º´, õ½Ä µî ¸¸¼ºÁúȯÀÇ Áõ°¡·Î ÀÎÇØ Ä¿³ØÆ¼µå ¾à¹°Àü´Þ ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡´Â µðÁöÅÐ Ç÷§ÆûÀ» ÅëÇØ ½Ç½Ã°£ ¸ð´ÏÅ͸µ, ¾Ë¸², Çǵå¹éÀ» Á¦°øÇÔÀ¸·Î½á ȯÀÚÀÇ º¹¾à ¼øÀÀµµ¸¦ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÇ·á¿¡ IoT°¡ ÅëÇյǸ鼭 ÀÌ·¯ÇÑ ±â±âÀÇ Ã¤ÅÃÀÌ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¹«¼± ¿¬°á ¹× ¸ð¹ÙÀÏ ¾ÖÇø®ÄÉÀ̼ǰú °°Àº ±â¼ú ¹ßÀüÀº ÀÇ·á Àü¹®°¡ÀÇ ¿ø°Ý ¸ð´ÏÅ͸µÀ» °¡´ÉÇϰÔÇÔÀ¸·Î½á Ä¡·á °á°ú¸¦ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½º¸¶Æ® ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÅõÀÚ È®´ë¿Í ÀçÅà ÀÇ·áÀÇ È°¼ºÈ­´Â È¿°úÀûÀ̰í È¿À²ÀûÀÎ ¾à¹° Åõ¿© ½Ã½ºÅÛ¿¡ ´ëÇÑ Àü ¼¼°è ¼ö¿ä¸¦ ÃæÁ·½ÃŰ¸ç ½ÃÀåÀ» Ȱ¼ºÈ­½Ã۰í ÀÖ½À´Ï´Ù.

Ä¿³ØÆ¼µå ¾à¹°Àü´Þ ±â±â ½ÃÀå : ÁÖ¿ä °í·Á »çÇ×

´ç»çÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®°¡ °øÀ¯ÇÑ ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â) µ¿¾È ¸Å³â ¾à 23.5%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¦Ç° À¯Çüº°·Î´Â ÅëÇÕÇü µð¹ÙÀ̽º ºÎ¹®ÀÌ 2023³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµÆ½À´Ï´Ù.

¿ëµµº°·Î´Â 2023³â ´ç´¢º´ ºÎ¹®ÀÌ ÁÖ¿ä À¯ÇüÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ¸ÅÃâ 1À§

Ä¿³ØÆ¼µå ¾à¹°Àü´Þ ±â±â ½ÃÀå : ¼¼ºÐÈ­ ºÐ¼®

¼¼°è Ä¿³ØÆ¼µå ¾à¹°Àü´Þ ±â±â ½ÃÀåÀº Á¦Ç° À¯Çü, ÀÀ¿ë ºÐ¾ß, Åõ¿© °æ·Î, Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù. Á¦Ç° À¯Çü¿¡ µû¶ó ½ÃÀåÀº µ¶¸³Çü ÄÄÆ÷³ÍÆ®, ¼ÒÇÁÆ®¿þ¾î ¹× ÅëÇÕ ÀåÄ¡ µî ¼¼ °¡Áö·Î ³ª´¹´Ï´Ù. Ä¿³ØÆ¼µå ¾à¹°Àü´Þ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ´Â °ÍÀº ÅëÇÕ ÀåÄ¡ ºÐ¾ßÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡´Â ¾à¹°Àü´Þ ¸ÞÄ¿´ÏÁò°ú ³»ÀåµÈ ¿¬°á ±â´ÉÀ» °áÇÕÇÏ¿© ½Ç½Ã°£À¸·Î ¿øÈ°ÇÑ ÃßÀû, ¸ð´ÏÅ͸µ ¹× µ¥ÀÌÅÍ °øÀ¯¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÆíÀǼº, ȯÀÚÀÇ º¹¾à ¼øÀÀµµ Çâ»ó, µðÁöÅÐ ÀÇ·á ½Ã½ºÅÛ°úÀÇ ÅëÇÕ ±â´É µîÀÌ ÀÌ ÀåÄ¡ÀÇ º¸±ÞÀ» ÃËÁøÇÏ´Â ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. °³ÀÎÈ­µÇ°í È¿À²ÀûÀÎ ¾à¹° Åõ¿©¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó, ÅëÇÕÇü µð¹ÙÀ̽º´Â ƯÈ÷ ´ç´¢º´, õ½Ä µî ¸¸¼ºÁúȯ °ü¸®¿¡ ÀÖ¾î ÀÇ·áÁø°ú ȯÀÚµé »çÀÌ¿¡¼­ ¼±È£µÇ´Â ¼±ÅÃÀÌ µÇ°í ÀÖ½À´Ï´Ù.

Åõ¿© °æ·Îº°(ºñ°æ±¸, ÈíÀÔ) : Ä¿³ØÆ¼µå ¾à¹°Àü´Þ ±â±â ½ÃÀåÀº ºñ°æ±¸ Åõ¿© ºÎ¹®ÀÌ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ´ç´¢º´°ú °°Àº ¸¸¼ºÁúȯÀÇ ³ôÀº À¯º´·ü°ú Ä¿³ØÆ¼µå Àν¶¸° Ææ°ú °°Àº ÀÚ°¡ Åõ¾à ÀåÄ¡ÀÇ Ã¤Åà Áõ°¡°¡ ÀÌ ºÎ¹®ÀÇ ¿ìÀ§¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ºñ°æ±¸ Åõ¿© ÀåÄ¡´Â Á¤È®ÇÑ Åõ¾à, »ç¿ë ÆíÀǼº, ½Ç½Ã°£ µ¥ÀÌÅÍ ÃßÀûÀ» ÅëÇÑ È¯ÀÚ ¼øÀÀµµ Çâ»ó µîÀÇ ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ»ç ±â¹Ý Àü´ÞÀÌ ÇÊ¿äÇÑ »ý¹°ÇÐÀû Á¦Á¦ÀÇ Áõ°¡´Â Ä¿³ØÆ¼µå ºñ°æ±¸¿ë ±â±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½ÃÄÑ ½ÃÀå¿¡¼­ÀÇ ¼±µµÀû ÁöÀ§¸¦ ´õ¿í °ø°íÈ÷ Çϰí ÀÖ½À´Ï´Ù.

¿ëµµº°(õ½Ä, COPD, ´ç´¢º´ °ü¸®, ±âŸ(ÀÚ°¡¸é¿ªÁúȯ, ´Ù¹ß¼º °æÈ­Áõ µî)) : ´ç´¢º´ °ü¸® ºÐ¾ß°¡ Ä¿³ØÆ¼µå ¾à¹°Àü´Þ ±â±â ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â Àü ¼¼°è ´ç´¢º´ À¯º´·üÀÇ Áõ°¡¿Í ½º¸¶Æ® Àν¶¸° Ææ ¹× Ç÷´ç ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀÇ Ã¤Åà Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡´Â Ä¡·á °èȹ ÁؼöÀ²À» ³ôÀ̰í, ½Ç½Ã°£ ¸ð´ÏÅ͸µ ¹× µ¥ÀÌÅÍ °øÀ¯ ±â´ÉÀ» Á¦°øÇÏ¿© ȯÀÚÀÇ Ä¡·á °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. µðÁöÅÐ Çコ ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ°¡ È®´ëµÇ°í ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó, ´ç´¢º´ °ü¸® ºÐ¾ß´Â °è¼ÓÇØ¼­ ½ÃÀå ¼ö¿äÀÇ ´ëºÎºÐÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

Ä¿³ØÆ¼µå ¾à¹°Àü´Þ ±â±â ½ÃÀå : Áö¿ªº° ºÐ¼®

¿¬°áÇü ¾à¹°Àü´Þ ±â±â ½ÃÀåÀº ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼­ °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â ¼±ÁøÈ­µÈ ÀÇ·á ÀÎÇÁ¶ó, ³ôÀº µðÁöÅÐ Çコ ¼Ö·ç¼Ç µµÀÔ·ü, ´ç´¢º´, õ½Ä µî ¸¸¼ºÁúȯ ȯÀÚ ¼ö°¡ ¸¹¾Æ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. À¯·´Àº ÀÇ·á µðÁöÅÐÈ­¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖÀ¸¸ç, ³ëÀÎ Àα¸°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¹Ý¸é, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·á ÅõÀÚ Áõ°¡, ½º¸¶Æ®Æù »ç¿ë·ü Áõ°¡, Ä¿³ØÆ¼µå µð¹ÙÀ̽º¿¡ ´ëÇÑ Á¢±Ù¼º È®´ë·Î ÀÎÇØ ºü¸¥ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ¶óƾ¾Æ¸Þ¸®Ä«¿Í Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ½ÅÈï±¹µéµµ ÀÇ·á Á¢±Ù¼º Çâ»óÀ¸·Î ÀáÀç·ÂÀ» ¹ßÈÖÇϰí ÀÖ½À´Ï´Ù.

Ä¿³ØÆ¼µå ¾à¹°Àü´Þ ±â±â ½ÃÀå : °æÀï ±¸µµ

¾à¹°Àü´Þ ±â±â ½ÃÀåÀº °æÀïÀÌ Ä¡¿­Çϰí ÁÖ¿ä ±â¾÷µéÀÌ Çõ½Å°ú Àü·«Àû Á¦ÈÞ¿¡ ÁýÁßÇϰí ÀÖÀ¸¸ç, Propeller Health, Phillips-Medisize, Teva Pharmaceuticals, Adherium°ú °°Àº ±â¾÷µéÀº ½º¸¶Æ® ±â¼úÀ» Ȱ¿ëÇÏ¿© ȯÀÚ ¼øÀÀµµ ¹× ¸ð´ÏÅ͸µÀ» °­È­Çϰí ÀÖ½À´Ï´Ù. ȯÀÚ ¼øÀÀµµ ¹× ¸ð´ÏÅ͸µÀ» °­È­Çϱâ À§ÇØ ½º¸¶Æ® ±â¼úÀ» Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù. Á¦¾àȸ»ç¿Í ÇÏÀÌÅ×Å© ±â¾÷ÀÇ Á¦È޴ ÷´Ü ±â±â °³¹ßÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ½ºÅ¸Æ®¾÷µéµµ AI ±â¹Ý ¼Ö·ç¼ÇÀ¸·Î ½ÃÀå¿¡ ÁøÀÔÇϸ鼭 °æÀïÀÌ Ä¡¿­ÇØÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °¢ ¾÷üµéÀº ±ÔÁ¦ ¿ä°ÇÀ» ÃæÁ·ÇÏ°í »ç¿ë ÆíÀǼºÀ» °³¼±Çϱâ À§ÇØ ¿¬±¸°³¹ß¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯ °ü¸®¿¡ Ä¿³ØÆ¼µå µð¹ÙÀ̽º°¡ µµÀԵǸ鼭 ÀÌ ¿ªµ¿ÀûÀÎ ½ÃÀå¿¡¼­ÀÇ °æÀïÀº ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Ä¿³ØÆ¼µå ¾à¹°Àü´Þ ±â±â ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Ä¿³ØÆ¼µå ¾à¹°Àü´Þ ±â±âÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå Ä¿³ØÆ¼µå ¾à¹°Àü´Þ ±â±â ½ÃÀå : »ê¾÷ ºÐ¼®

Á¦5Àå Ä¿³ØÆ¼µå ¾à¹°Àü´Þ ±â±â ½ÃÀå : ³ô¾ÆÁö´Â ÁöÁ¤ÇÐÀû ±äÀåÀÇ ¿µÇâ

Á¦6Àå Ä¿³ØÆ¼µå ¾à¹°Àü´Þ ±â±â ½ÃÀå »óȲ

Á¦7Àå Ä¿³ØÆ¼µå ¾à¹°Àü´Þ ±â±â ½ÃÀå : Á¦Ç° Á¾·ùº°

Á¦8Àå Ä¿³ØÆ¼µå ¾à¹°Àü´Þ ±â±â ½ÃÀå : ¿ëµµº°

Á¦9Àå Ä¿³ØÆ¼µå ¾à¹°Àü´Þ ±â±â ½ÃÀå : Åõ¿© °æ·Îº°

Á¦10Àå Ä¿³ØÆ¼µå ¾à¹°Àü´Þ ±â±â ½ÃÀå : Áö¿ªº°

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® : Ä¿³ØÆ¼µå ¾à¹°Àü´Þ ±â±â ¾÷°è

Á¦12Àå AnalystView Àü¹æÀ§Àû ºÐ¼®

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Connected Drug Delivery Devices Market size was valued at USD 5,123.45 Billion in 2023, expanding at a CAGR of 23.5% from 2024 to 2032.

Connected drug delivery devices integrate advanced digital technology with traditional drug delivery systems to enhance patient care. These devices enable real-time monitoring, data sharing, and adherence tracking, offering personalized treatment options. Commonly used in chronic disease management, they support conditions like diabetes, asthma, and cardiovascular disorders. With features such as Bluetooth connectivity and smartphone integration, connected drug delivery devices improve therapeutic outcomes while empowering patients and healthcare providers with actionable insights for better disease management.

Connected Drug Delivery Devices Market- Market Dynamics

Increasing Demand for Smart and Efficient Drug Delivery Solutions

The increasing prevalence of chronic diseases, such as diabetes and asthma, is driving demand for connected drug delivery devices. These devices enhance patient adherence by providing real-time monitoring, reminders, and feedback through digital platforms. Rising awareness about personalized medicine and the integration of IoT in healthcare are further boosting their adoption. Technological advancements, including wireless connectivity and mobile applications, improve treatment outcomes by enabling remote monitoring for healthcare professionals. Additionally, growing investments in smart healthcare solutions and the push for home-based care are fueling the market, addressing the need for effective and efficient drug administration systems globally.

Connected Drug Delivery Devices Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 23.5% over the forecast period (2024-2032)

Based on Product Type segmentation, the integrated devices segment was predicted to show maximum market share in the year 2023

Based on application segmentation, the diabetes segment was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Connected Drug Delivery Devices Market- Segmentation Analysis:

The Global Connected Drug Delivery Devices Market is segmented based on Product Type, Application, Route of Administration, and Region. The market is divided into three categories based on Product Type: Standalone Components & Software and Integrated Devices. The Integrated Devices segment dominates the Connected Drug Delivery Devices Market. These devices combine drug delivery mechanisms with built-in connectivity features, enabling seamless tracking, monitoring, and data sharing in real-time. Their convenience, improved patient adherence, and ability to integrate into digital healthcare systems have driven widespread adoption. With the growing demand for personalized and efficient drug administration, integrated devices are becoming the preferred choice among healthcare providers and patients, particularly in managing chronic conditions like diabetes and asthma.

Based on route of administration: Parenteral and Inhalational. The parenteral segment dominates the Connected Drug Delivery Devices Market. The high prevalence of chronic diseases like diabetes and the increasing adoption of self-administration devices such as connected insulin pens drive this dominance. Parenteral devices offer precise dosing, ease of use, and enhanced patient compliance through real-time data tracking. Additionally, the rise in biologics requiring injection-based delivery further boosts demand for connected parenteral devices, solidifying their leading position in the market.

By application: Asthma, COPD, Diabetes Management and Others (autoimmune diseases, multiple sclerosis, etc.). The Diabetes Management segment dominates the Connected Drug Delivery Devices Market. This is attributed to the rising prevalence of diabetes globally and the increasing adoption of smart insulin pens and glucose monitoring systems. These devices offer improved adherence to treatment plans, real-time monitoring, and data sharing capabilities, enhancing patient outcomes. With growing investments in digital health technologies and a focus on personalized care, diabetes management continues to drive the majority of the demand in this market.

Connected Drug Delivery Devices Market- Geographical Insights

The Connected Drug Delivery Devices Market shows strong growth across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America leads due to its advanced healthcare infrastructure, high adoption rates of digital health solutions, and a large patient base for chronic conditions like diabetes and asthma. Europe follows with significant investments in healthcare digitalization and a growing elderly population. Meanwhile, Asia-Pacific exhibits rapid growth driven by increasing healthcare investments, rising smartphone usage, and expanding access to connected devices. Emerging economies in Latin America and the Middle East & Africa also display potential due to improving healthcare access.

Connected Drug Delivery Devices Market- Competitive Landscape:

The Connected Drug Delivery Devices Market is highly competitive, with key players focusing on innovation and strategic collaborations. Companies such as Propeller Health, Phillips-Medisize, Teva Pharmaceuticals, and Adherium are leveraging smart technology to enhance patient adherence and monitoring. Partnerships between pharmaceutical firms and tech companies are driving the development of advanced devices. Startups are also entering the market with AI-enabled solutions, intensifying competition. Additionally, players are investing in R&D to meet regulatory requirements and improve usability. The adoption of connected devices in managing chronic diseases is further accelerating competition in this dynamic market.

Recent Developments:

In February 2022, AptarGroup Inc. introduced the HeroTracker Sense, a digital solution that transforms traditional metered-dose inhalers into smart devices for enhanced medication management, particularly for asthma and COPD patients. This tool integrates with the BreatheSmart app, improving adherence and disease management.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Connected Drug Delivery Devices Market Overview

2. Executive Summary

3. Connected Drug Delivery Devices Key Market Trends

4. Connected Drug Delivery Devices Industry Study

5. Connected Drug Delivery Devices Market: Impact of Escalating Geopolitical Tensions

6. Connected Drug Delivery Devices Market Landscape

7. Connected Drug Delivery Devices Market - By Product Type

8. Connected Drug Delivery Devices Market - By Application

9. Connected Drug Delivery Devices Market - By Route of Administration

10. Connected Drug Delivery Devices Market- By Geography

11. Key Vendor Analysis- Connected Drug Delivery Devices Industry

12. 360 Degree Analyst View

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â